Rajeev Singh Raghuvanshi has been appointed as the new Drug Controller General of India (DCGI), Central Drugs Standard Control Organization (CDSCO). Rajeev Singh Raghuvanshi is a former Indian Pharmacopoeia Commission secretary-cum-scientific director.
Rajeev Singh Raghuvanshi will supersede Dr. PBN Prasad who is holding the position till 28th February 2023. The order which was released stated that Raghuvanshi will continue to be the DGCI till February 28, 2025.
Rajeev Raghuvanshi Appointed as New Drug Controller General of India- Key Points
- The Union Public Service Commission (UPSC) has recommended to the government his name as the successor to Dr. V G Somani, whose extended tenure will end in mid-February.
- The recommendation was later approved by the Health Ministry, followed by approval of the Appointments Committee of Cabinet led by Prime Minister Narendra Modi.
- Based on the assessment of bio-data of the eligible officers received and after holding personal talks with them on January 27 recommends Dr. Rajeev Singh Raghuvanshi for appointment to the post of Drug Controller (India) on a short-term contract basis.
- The DCGI heads the Central Drugs Standard Control Organisation (CDSCO) which is responsible for ensuring quality drug supply across the country.
- It also has the authority to give approval to new drugs and regulate clinical trials.
- Dr. Raghuvanshi has 14 granted US patents along with more than 250 published patent cooperation treaties and Indian patents.
- He has more than 25 publications in peer-reviewed journals and has co-authored six chapters in books.
- Meghana Pandit appoints as CEO of Oxford University Hospitals NHS Trust
- Rajesh Rai named as CMD of ITI Limited